These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24495043)

  • 1. Position paper: breast cancer screening, diagnosis, and treatment in Denmark.
    Christiansen P; Vejborg I; Kroman N; Holten I; Garne JP; Vedsted P; Møller S; Lynge E
    Acta Oncol; 2014 Apr; 53(4):433-44. PubMed ID: 24495043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer incidence after the introduction of mammography screening: what should be expected?
    Svendsen AL; Olsen AH; von Euler-Chelpin M; Lynge E
    Cancer; 2006 May; 106(9):1883-90. PubMed ID: 16572411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seventeen-years overview of breast cancer inside and outside screening in Denmark.
    Domingo L; Jacobsen KK; von Euler-Chelpin M; Vejborg I; Schwartz W; Sala M; Lynge E
    Acta Oncol; 2013 Jan; 52(1):48-56. PubMed ID: 22943386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of primary breast cancer. Consequences of mammographic screening in the municipality of Copenhagen].
    Hirsch FR; Mouridsen HT; Hansen OP; Jørgensen T; Blichert-Toft M; Rank FE; Jensen MB
    Ugeskr Laeger; 1996 Feb; 158(9):1218-21. PubMed ID: 8644426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964-2003 followed up to the end of 2006.
    Tryggvadóttir L; Gislum M; Bray F; Klint A; Hakulinen T; Storm HH; Engholm G
    Acta Oncol; 2010 Jun; 49(5):624-31. PubMed ID: 20429724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study.
    Olsen AH; Njor SH; Vejborg I; Schwartz W; Dalgaard P; Jensen MB; Tange UB; Blichert-Toft M; Rank F; Mouridsen H; Lynge E
    BMJ; 2005 Jan; 330(7485):220. PubMed ID: 15649904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why did the breast cancer lymph node status distribution improve in Denmark in the pre-mammography screening period of 1978-1994?
    Rostgaard K; Vaeth M; Rootzén H; Lynge E
    Acta Oncol; 2010 Apr; 49(3):313-21. PubMed ID: 20397766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes.
    Törnberg S; Kemetli L; Lynge E; Helene Olsen A; Hofvind S; Wang H; Anttila A; Hakama M; Nyström L
    Acta Oncol; 2006; 45(5):528-35. PubMed ID: 16864165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark.
    Utzon-Frank N; Vejborg I; von Euler-Chelpin M; Lynge E
    Cancer Epidemiol; 2011 Oct; 35(5):393-8. PubMed ID: 21239242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in breast cancer during three decades in Denmark: stage at diagnosis, surgical management and survival.
    Jensen AR; Madsen AH; Overgaard J
    Acta Oncol; 2008; 47(4):537-44. PubMed ID: 18465319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
    Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
    Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attending the breast screening programme after breast cancer treatment: a population-based study.
    de Munck L; Kwast A; Reiding D; de Bock GH; Otter R; Willemse PH; Siesling S
    Cancer Epidemiol; 2013 Dec; 37(6):968-72. PubMed ID: 24075800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
    Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
    Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and prevention of breast cancer in primary care.
    Tice JA; Kerlikowske K
    Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should we recommend screening mammography for women aged 40 to 49?
    Esserman L; Kerlikowske K
    Oncology (Williston Park); 1996 Mar; 10(3):357-64; discussion: 370-6. PubMed ID: 8820449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer mortality in organised mammography screening in Denmark: comparative study.
    Jørgensen KJ; Zahl PH; Gøtzsche PC
    BMJ; 2010 Mar; 340():c1241. PubMed ID: 20332505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mammographic screening in the municipality of Copenhagen. Results of the first screening round].
    Jørgensen T; Jensen LB; Duun S; Hirsch FR; Mouridsen HT; Blichert-Toft M; Rank FE; Christensen LH; Hansen AG; Nissen FH
    Ugeskr Laeger; 1996 Feb; 158(9):1212-7. PubMed ID: 8644425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overdiagnosis in organised mammography screening in Denmark. A comparative study.
    Jørgensen KJ; Zahl PH; Gøtzsche PC
    BMC Womens Health; 2009 Dec; 9():36. PubMed ID: 20028513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammography screening. Benefits, harms, and informed choice.
    Jørgensen KJ
    Dan Med J; 2013 Apr; 60(4):B4614. PubMed ID: 23651722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.